M
Massive Bio
Massive Bio is building a global real time cancer database with patient consented clinical and genomic data.
About Massive Bio
Massive Bio is building a real-time cancer database powered by patient-consented clinical and genomic data, transforming every cancer patient’s journey as a catalyst for better drug development and commercial activation. It introduces patient-consented data into the healthcare data ecosystem, enabling clinical and genomic data collection through active patient participation.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 100
- Open positions
- None listed
- Dealroom signal
- 69.1/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Testing, Biotechnology, Oncology, Drug Development, Core AI, Biotech and Pharma, AI Applications, medical testing
- Technology
- Artificial Intelligence
- Business model
- SaaS
- Client focus
- B2B
- Investment activity
- 1 company, latest Aug 2026
- Capital deployed
- —
- Preferred round
- GROWTH EQUITY NON VC
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Dec 2022 | $17M | $66M | International Finance Corporation · ImpactAssets · Toyota Financial Services · Kenan Turnacioğlu | ↗ |
| EARLY VC✓Equity / VC | Jun 2022 | $9M | $36M | German Investment Corporation · Revo Capital · Kenan Turnacioğlu | ↗ |
Growth signals
Latest recorded traffic for Massive Bio is 280K monthly website visits, up 40% over the last three months. Massive Bio's team declined 2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Massive Bio in the Boca Raton ecosystem
The Massive Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Revo Capital
Cavendish Impact Capital
Series A8 investors entered at this stage
500 Global
UL Ventures- KTKenan Turnacioğlu
German Investment Corporation
International Finance Corporation
ImpactAssets
Toyota Financial Services
SiteGround
Other known investors3 additional known investors
e2vc
Small Business Innovation Research
UL Solutions
Source: Dealroom Talent Intelligence.
See Massive Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









